These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17329974)

  • 1. Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma.
    Montaner S
    Cell Cycle; 2007 Feb; 6(4):438-43. PubMed ID: 17329974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
    Sodhi A; Chaisuparat R; Hu J; Ramsdell AK; Manning BD; Sausville EA; Sawai ET; Molinolo A; Gutkind JS; Montaner S
    Cancer Cell; 2006 Aug; 10(2):133-43. PubMed ID: 16904612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene.
    Martin D; Nguyen Q; Molinolo A; Gutkind JS
    Oncogene; 2014 May; 33(18):2405-12. PubMed ID: 23708663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.
    Jham BC; Ma T; Hu J; Chaisuparat R; Friedman ER; Pandolfi PP; Schneider A; Sodhi A; Montaner S
    PLoS One; 2011 Apr; 6(4):e19103. PubMed ID: 21559457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.
    Chaisuparat R; Hu J; Jham BC; Knight ZA; Shokat KM; Montaner S
    Cancer Res; 2008 Oct; 68(20):8361-8. PubMed ID: 18922908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
    Sodhi A; Montaner S; Gutkind JS
    FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
    Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
    Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor.
    Sodhi A; Montaner S; Patel V; Gómez-Román JJ; Li Y; Sausville EA; Sawai ET; Gutkind JS
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4821-6. PubMed ID: 15047889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic Kaposi's sarcoma treated with topical rapamycin.
    Díaz-Ley B; Grillo E; Ríos-Buceta L; Paoli J; Moreno C; Vano-Galván S; Jaén-Olasolo P
    Dermatol Ther; 2015; 28(1):40-3. PubMed ID: 25314592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
    Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
    Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.
    Montaner S; Sodhi A; Molinolo A; Bugge TH; Sawai ET; He Y; Li Y; Ray PE; Gutkind JS
    Cancer Cell; 2003 Jan; 3(1):23-36. PubMed ID: 12559173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
    Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
    Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3Kγ mediates kaposi's sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis.
    Martin D; Galisteo R; Molinolo AA; Wetzker R; Hirsch E; Gutkind JS
    Cancer Cell; 2011 Jun; 19(6):805-13. PubMed ID: 21665152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
    Dezube BJ; Sullivan R; Koon HB
    J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene.
    Jham BC; Montaner S
    J Cell Biochem; 2010 May; 110(1):1-9. PubMed ID: 20213674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma virally encoded, G-protein-coupled receptor: a paradigm for paracrine transformation.
    Martin D; Gutkind JS
    Methods Enzymol; 2009; 460():125-50. PubMed ID: 19446723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
    Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA
    PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis.
    Pati S; Cavrois M; Guo HG; Foulke JS; Kim J; Feldman RA; Reitz M
    J Virol; 2001 Sep; 75(18):8660-73. PubMed ID: 11507211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.
    Bais C; Van Geelen A; Eroles P; Mutlu A; Chiozzini C; Dias S; Silverstein RL; Rafii S; Mesri EA
    Cancer Cell; 2003 Feb; 3(2):131-43. PubMed ID: 12620408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
    Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
    Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.